Related Experiment Video
Updated: Jul 15, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA
Suping Zhang1, Teng Fei, Lixia Zhang
1Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing, China.
Abstract:
Smad7 plays an essential role in the negative-feedback regulation of transforming growth factor beta (TGF-beta) signaling by inhibiting TGF-beta signaling at the receptor level. It can interfere with binding to type I receptors and thus activation of receptor-regulated Smads or recruit the E3 ubiquitin ligase Smurf to receptors and thus target them for degradation. Here, we report that Smad7 is predominantly localized in the nucleus of Hep3B cells. The targeted expression of Smad7 in the nucleus conferred superior inhibitory activity on TGF-beta signaling, as determined by reporter assay in mammalian cells and by its effect on zebrafish embryogenesis. Furthermore, Smad7 repressed Smad3/4-, Smad2/4-, and Smad1/4-enhanced reporter gene expression, indicating that Smad7 can function independently of type I receptors. An oligonucleotide precipitation assay revealed that Smad7 can specifically bind to the Smad-responsive element via its MH2 domain, and DNA-binding activity was further confirmed in vivo with the promoter of PAI-1, a TGF-beta target gene, by chromatin immunoprecipitation. Finally, we provide evidence that Smad7 disrupts the formation of the TGF-beta-induced functional Smad-DNA complex. Our findings suggest that Smad7 inhibits TGF-beta signaling in the nucleus by a novel mechanism.
Insights
Smad7 inhibits transforming growth factor beta (TGF-beta) signaling by binding DNA in the nucleus. This novel mechanism, independent of cell receptors, offers new insights into TGF-beta pathway regulation.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Transforming growth factor beta (TGF-beta) signaling is crucial for cellular processes.
- Smad7 is known to negatively regulate TGF-beta signaling at the receptor level.
- The precise mechanism and localization of Smad7's inhibitory function require further elucidation.
Purpose of the Study:
- To investigate the nuclear localization and function of Smad7 in TGF-beta signaling.
- To determine if Smad7 can inhibit TGF-beta signaling independently of cell surface receptors.
- To elucidate the novel molecular mechanism by which Smad7 regulates TGF-beta pathway activity.
Main Methods:
- Reporter assays in mammalian cells and zebrafish embryogenesis studies.
- Oligonucleotide precipitation assays to assess DNA binding.
- Chromatin immunoprecipitation (ChIP) to confirm in vivo DNA binding to target gene promoters.
Main Results:
- Smad7 predominantly localizes to the nucleus in Hep3B cells.
- Nuclear Smad7 expression enhances inhibition of TGF-beta signaling.
- Smad7 directly binds to Smad-responsive elements via its MH2 domain, independent of type I receptors.
- Smad7 disrupts the formation of functional Smad-DNA complexes in TGF-beta signaling.
Conclusions:
- Smad7 inhibits TGF-beta signaling through a novel nuclear mechanism involving direct DNA binding.
- This nuclear function of Smad7 is independent of its previously known receptor-level inhibitory actions.
- These findings reveal a new layer of regulation within the TGF-beta signaling pathway.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
11:06Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
Related Concept Videos
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
The JAK-STAT Signaling Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...